Net debt/EBITDA společnosti Veru Inc
Jaká je hodnota metriky Net debt/EBITDA společnosti Veru Inc?
Hodnota metriky Net debt/EBITDA společnosti Veru Inc je 2.38
Jaká je definice metriky Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA společností v sektoru Health Care sektor na NASDAQ ve srovnání se společností Veru Inc
Čemu se věnuje společnost Veru Inc?
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
Firmy s metrikou net debt/ebitda podobnou společnosti Veru Inc
- Hodnota metriky Net debt/EBITDA společnosti Schultze Special Purpose Acquisition Corp II je 2.37
- Hodnota metriky Net debt/EBITDA společnosti KLA je 2.37
- Hodnota metriky Net debt/EBITDA společnosti Infineon Technologies AG je 2.37
- Hodnota metriky Net debt/EBITDA společnosti RedFlow je 2.37
- Hodnota metriky Net debt/EBITDA společnosti DFS Furniture plc je 2.37
- Hodnota metriky Net debt/EBITDA společnosti Abbott Laboratories je 2.37
- Hodnota metriky Net debt/EBITDA společnosti Veru Inc je 2.38
- Hodnota metriky Net debt/EBITDA společnosti Theriva Biologics Inc je 2.38
- Hodnota metriky Net debt/EBITDA společnosti Iwatani je 2.38
- Hodnota metriky Net debt/EBITDA společnosti Rotala PLC je 2.38
- Hodnota metriky Net debt/EBITDA společnosti Ollies Bargain Outlet Inc je 2.38
- Hodnota metriky Net debt/EBITDA společnosti Montero Mining and Exploration je 2.38
- Hodnota metriky Net debt/EBITDA společnosti E2 Metals je 2.38